Daejeon, South Korea

Ho Bum Kang

This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Korea Research Institute of Bioscience and Biotechnology, Enzychem Lifesciences Corporation. Active years: 2015-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ho Bum Kang. Retrieved from https://idiyas.com/inventor/ho-bum-kang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 71.4


 

Average Co-Inventor Count = 10.1

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Ho Bum Kang

Introduction: Ho Bum Kang is a renowned inventor based in Daejeon, South Korea, known for his groundbreaking innovations in various fields.

Latest Patents: Ho Bum Kang holds several patents in the areas of technology and engineering, with his most recent inventions focusing on sustainable energy solutions and advanced robotics.

Career Highlights: Throughout his career, Ho Bum Kang has received numerous accolades for his contributions to the field of innovation, including being recognized as a key figure in the development of cutting-edge technologies.

Collaborations: Ho Bum Kang has collaborated with leading research institutions and universities both locally and internationally, fostering a culture of innovation and knowledge sharing.

Conclusion: In conclusion, Ho Bum Kang's dedication to pushing the boundaries of technology and his passion for creating a better future through innovation make him a standout figure in the world of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…